Die Übereinstimmung verschiedener Messmethoden des Nail Psoriasis Severity Index (NAPSI) und deren Korrelation mit dem Dermatology Life Quality Index (DLQI)

Publisher： John Wiley & Sons Inc

E-ISSN： 1610-0387|12|11|1051-1053

ISSN： 1610-0379

Source： JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, Vol.12, Iss.11, 2014-11, pp. : 1051-1053

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI)

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 3, 2015-03 ,pp. : 452-456

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sustained Psoriasis Area and Severity Index, Dermatology Life Quality Index and EuroQol‐5D response of biological treatment in psoriasis: 10 years of real‐world data in the Swedish National Psoriasis Register

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 1, 2018-01 ,pp. : e81-e81

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sustained Psoriasis Area and Severity Index, Dermatology Life Quality Index and EuroQol‐5D response of biological treatment in psoriasis: 10 years of real‐world data in the Swedish National Psoriasis Register

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 1, 2018-01 ,pp. : 245-252

John Wiley & Sons Inc

Access to resources Recommend Favorite

Time, Psoriasis Area and Severity Index and Dermatology Life Quality Index of patients with psoriasis who drop out of clinical trials on etanercept because of lack of efficacy: a pooled analysis from 10 clinical trials

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : 400-405

John Wiley & Sons Inc

Access to resources Recommend Favorite

Time, Psoriasis Area and Severity Index and Dermatology Life Quality Index of patients with psoriasis who drop out of clinical trials on etanercept because of lack of efficacy: a pooled analysis from 10 clinical trials

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 178, Iss. 2, 2018-02 ,pp. : e166-e166

John Wiley & Sons Inc

Access to resources Recommend Favorite